CD20-directed Cytolytic Antibody [EPC] - N0000175657

Pharmacologic Code	N0000175657
Pharmacologic Name	CD20-directed Cytolytic Antibody
Pharmacologic Uses	CD20-directed cytolytic antibody
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 15 products whose active ingredient are classified under the same pharmacologic class CD20-directed Cytolytic Antibody [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0069-0238	Ruxience	Non-Proprietary Name: Rituximab-pvvr	Injection, Solution	Intravenous	Pfizer Laboratories Div Pfizer Inc	ACTIVE
	0069-0249	Ruxience	Non-Proprietary Name: Rituximab-pvvr	Injection, Solution	Intravenous	Pfizer Laboratories Div Pfizer Inc	ACTIVE
	0078-0669	Arzerra	Non-Proprietary Name: Ofatumumab	Injection, Solution	Intravenous	Novartis Pharmaceuticals Corporation	ACTIVE
	0078-0690	Arzerra	Non-Proprietary Name: Ofatumumab	Injection, Solution	Intravenous	Novartis Pharmaceuticals Corporation	ACTIVE
	0078-1007	Kesimpta	Non-Proprietary Name: Ofatumumab	Injection, Solution	Subcutaneous	Novartis Pharmaceuticals Corporation	ACTIVE
	50242-051	Rituxan	Non-Proprietary Name: Rituximab	Injection, Solution	Intravenous	Genentech, Inc.	ACTIVE
	50242-053	Rituxan	Non-Proprietary Name: Rituximab	Injection, Solution	Intravenous	Genentech, Inc.	ACTIVE
	50242-070	Gazyva	Non-Proprietary Name: Obinutuzumab	Injection, Solution, Concentrate	Intravenous	Genentech, Inc.	ACTIVE
	50242-108	Rituxan Hycela	Non-Proprietary Name: Rituximab And Hyaluronidase	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-109	Rituxan Hycela	Non-Proprietary Name: Rituximab And Hyaluronidase	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-150	Ocrevus	Non-Proprietary Name: Ocrelizumab	Injection	Intravenous	Genentech, Inc.	ACTIVE
	55513-224	Riabni	Non-Proprietary Name: Rituximab-arrx	Injection, Solution	Intravenous	Amgen Inc	ACTIVE
	55513-326	Riabni	Non-Proprietary Name: Rituximab-arrx	Injection, Solution	Intravenous	Amgen Inc	ACTIVE
	63459-103	Truxima	Non-Proprietary Name: Rituximab-abbs	Injection, Solution	Intravenous	Cephalon, Inc.	ACTIVE
	63459-104	Truxima	Non-Proprietary Name: Rituximab-abbs	Injection, Solution	Intravenous	Cephalon, Inc.	ACTIVE